Delivery Order SPE2DB20D2014-SPE2DB25FC75Z
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency Medical Supply Chain on July 28, 2025, valued at $2,055.13 for the supply of Modafinil 100 mg tablets in 30-unit quantities. This is a firm fixed-price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion on July 29, 2025, with fulfillment to occur at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,775.39 for Modafinil 100 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract utilizes no set-aside designation and represents a competitive award to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,276.86 to AmerisourceBergen Drug Corp for Modafinil 100 mg tablets (30-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.37 to AmerisourceBergen Drug Corp for 30-count tablets of Modafinil 100 mg, with completion scheduled for August 14, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office...
- The Defense Logistics Agency awarded a $3,843.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Modafinil 100 mg tablets in 30-count quantities. This non-set-aside delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, with performance conducted at the contractor's Conshohocken, Pennsylvania facility....
- The Defense Logistics Agency awarded a delivery order valued at $1,724.25 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on July 24, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) under a firm fixed-price contract valued at $4,265.14. The award was made on July 18, 2025, with an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in Conshohocken, PA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,665.16 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in 30-count units. This competitive delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, carries firm fixed pricing and represents no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Modafinil 100 mg tablets in 30-count packaging, with a ceiling value of $1,040.59. This non-set-aside, competitively awarded contract features firm fixed price pricing and has an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor and major pharmaceutical distributor providing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) under a firm fixed-price contract valued at $5,065.11, with an ultimate completion date of August 15, 2025. This non-set-aside delivery order was competitively awarded on August 14, 2025, with performance at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC75ZDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order for Modafinil 100 mg tablets (quantity 30s) by the Defense Logistics Agency on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract is valued at $3,939.53 and is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This delivery order represents a child contract under AmerisourceBergen's substantial $1 billion indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement needs across multiple therapeutic domains for military and veteran healthcare systems, demonstrating its established capability to meet defense-related pharmaceutical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/15/25 |